AGN-2979

AGN-2979
	[[File:\|frameless\|220px\|alt=\|]]
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

AGN-2979.svg

Experimental drug

AGN-2979 is an experimental drug that has been investigated for its potential therapeutic effects. It is primarily studied in the context of neurological disorders and psychiatric conditions. The drug is part of a class of compounds known as receptor antagonists, which work by blocking specific receptors in the brain and nervous system.

Mechanism of Action

AGN-2979 functions as a receptor antagonist, specifically targeting the serotonin receptors. By inhibiting these receptors, the drug aims to modulate the levels of serotonin in the brain, which is a key neurotransmitter involved in mood regulation, anxiety, and other cognitive functions.

Potential Applications

The primary focus of research on AGN-2979 has been its application in treating conditions such as depression, anxiety disorders, and schizophrenia. Preliminary studies suggest that it may help alleviate symptoms by restoring the balance of neurotransmitters in the brain.

Clinical Trials

As of the latest updates, AGN-2979 is in the early stages of clinical trials. These trials are designed to assess its safety, efficacy, and potential side effects in human subjects. The outcomes of these trials will determine whether AGN-2979 can proceed to later stages of drug development and potential approval by regulatory agencies.

Side Effects

Like many experimental drugs, AGN-2979 may have side effects. Commonly reported side effects in early trials include nausea, headache, and dizziness. More serious side effects are still under investigation and will be closely monitored in ongoing studies.

Conclusion

AGN-2979 represents a promising avenue of research in the field of neuropharmacology. Its development is being closely watched by the medical community, and further studies will elucidate its potential as a therapeutic agent.

- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.

NYC weight loss doctor appointments

Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.

Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC

Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.